Differential properties of human ACL and MCL stem cells may be responsible for their differential healing capacity

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Zhang, Jianying ^a   Pan, Tiffany ^a   Im, Hee Jeong ^b   Fu, Freddie H ^a   Wang, James H C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD44V ANTIGEN; CD45 ANTIGEN; CELL MARKER; NUCLEOSTEMIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEALING; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; KNEE LIGAMENT; MALE; MESENCHYMAL STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; TISSUE REPAIR; CELL CULTURE; IMMUNOHISTOCHEMISTRY; INJURY; METABOLISM; PHYSIOLOGY; STEM CELL; WOUND HEALING;

ADULT; ANTERIOR CRUCIATE LIGAMENT; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEDIAL COLLATERAL LIGAMENT, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; WOUND HEALING;

EID: 79957866890     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-68     Document Type: Article

References (59)

1. Frank CB, Jackson DW. The science of reconstruction of the anterior cruciate ligament. J Bone Joint Surg Am 1997, 79:1556-1576.
2. Barrack RL, Bruckner JD, Kneisl J, Inman WS, Alexander AH. The outcome of nonoperatively treated complete tears of the anterior cruciate ligament in active young adults. Clin Orthop Relat Res 1990, 259:192-199.
3. Woo SL, Niyibizi C, Matyas J, Kavalkovich K, Weaver-Green C, Fox RJ. Medial collateral knee ligament healing. Combined medial collateral and anterior cruciate ligament injuries studied in rabbits. Acta Orthop Scand 1997, 68:142-148. 10.3109/17453679709003997, 9174451.
4. Chen H, Tang Y, Li S, Shen Y, Liu X, Zhong C. Biologic characteristics of fibroblast cells cultured from the knee ligaments. Chin J Traumatol 2002, 5:92-96.
5. Bedi A, Kawamura S, Ying L, Rodeo SA. Differences in tendon graft healing between the intra-articular and extra-articular ends of a bone tunnel. HSS J 2009, 5:51-57. 10.1007/s11420-008-9096-1, 2642544, 19052716.
6. Beynnon BD, Fleming BC, Labovitch R, Parsons B. Chronic anterior cruciate ligament deficiency is associated with increased anterior translation of the tibia during the transition from non-weightbearing to weightbearing. J Orthop Res 2002, 20:332-337. 10.1016/S0736-0266(01)00115-2, 11918313.
7. Cao M, Stefanovic-Racic M, Georgescu HI, Fu FH, Evans CH. Does nitric oxide help explain the differential healing capacity of the anterior cruciate, posterior cruciate, and medial collateral ligaments?. Am J Sports Med 2000, 28:176-182.
8. Bray RC, Leonard CA, Salo PT. Correlation of healing capacity with vascular response in the anterior cruciate and medial collateral ligaments of the rabbit. J Orthop Res 2003, 21:1118-1123. 10.1016/S0736-0266(03)00078-0, 14554227.
9. Amiel D, Nagineni CN, Choi SH, Lee J. Intrinsic properties of ACL and MCL cells and their responses to growth factors. Med Sci Sports Exerc 1995, 27:844-851.
10. Yoshida M, Fujii K. Differences in cellular properties and responses to growth factors between human ACL and MCL cells. J Orthop Sci 1999, 4:293-298. 10.1007/s007760050106, 10436277.
11. Gao J, Caplan AI. Mesenchymal stem cells and tissue engineering for orthopaedic surgery. Chir Organi Mov 2003, 88:305-316.
12. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998, 16:406-413. 10.1002/jor.1100160403, 9747780.
13. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994, 56:283-294.
14. Caplan AI. The mesengenic process. Clin Plast Surg 1994, 21:429-435.
15. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228. 10.1089/107632701300062859, 11304456.
16. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295. 10.1091/mbc.E02-02-0105, 138633, 12475952.
17. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000, 109:235-242. 10.1046/j.1365-2141.2000.01986.x, 10848804.
18. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942. 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P, 11508446.
19. Risbud MV, Guttapalli A, Tsai TT, Lee JY, Danielson KG, Vaccaro AR, Albert TJ, Gazit Z, Gazit D, Shapiro IM. Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine 2007, 32:2537-2544. 10.1097/BRS.0b013e318158dea6, 17978651.
20. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000, 97:13625-13630. 10.1073/pnas.240309797, 17626, 11087820.
21. Gronthos S, Mrozik K, Shi S, Bartold PM. Ovine periodontal ligament stem cells: isolation, characterization, and differentiation potential. Calcif Tissue Int 2006, 79:310-317. 10.1007/s00223-006-0040-4, 17033723.
22. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007, 13:1219-1227. 10.1038/nm1630, 17828274.
23. Zhang J, Wang JH. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 2010, 11:10. 10.1186/1471-2474-11-10, 2822826, 20082706.
24. Furumatsu T, Hachioji M, Saiga K, Takata N, Yokoyama Y, Ozaki T. Anterior cruciate ligament-derived cells have high chondrogenic potential. Biochem Biophys Res Commun 2010, 391:1142-1147. 10.1016/j.bbrc.2009.12.044, 20006576.
25. Normile D. Cell proliferation. Common control for cancer, stem cells. Science 2002, 298:1869. 10.1126/science.298.5600.1869, 12471231.
26. Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002, 16:2991-3003. 10.1101/gad.55671, 187487, 12464630.
27. Kafienah W, Mistry S, Williams C, Hollander AP. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. Stem Cells 2006, 24:1113-1120. 10.1634/stemcells.2005-0416, 16282439.
28. Pesce M, Gross MK, Scholer HR. In line with our ancestors: Oct-4 and the mammalian germ.[erratum appears in Bioessays 1998 Dec;20:1056]. Bioessays 1998, 20:722-732. 10.1002/(SICI)1521-1878(199809)20:9<722::AID-BIES5>3.0.CO;2-I, 9819561.
29. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation.[see comment]. Cell 2005, 123:917-929. 10.1016/j.cell.2005.08.040, 16325584.
30. Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004, 22:225-235. 10.1634/stemcells.22-2-225, 14990861.
31. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000, 18:399-404. 10.1038/74447, 10748519.
32. Kannagi R, Cochran NA, Ishigami F, Hakomori S, Andrews PW, Knowles BB, Solter D. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 1983, 2:2355-2361. 555457, 6141938.
33. Brimble SN, Sherrer ES, Uhl EW, Wang E, Kelly S, Merrill AH, Robins AJ, Schulz TC. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 2007, 25:54-62. 10.1634/stemcells.2006-0232, 17008424.
34. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev 2008, 22:1987-1997. 10.1101/gad.1689808, 2735345, 18676805.
35. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007, 109:1743-1751. 10.1182/blood-2005-11-010504, 17062733.
36. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78:55-62.
37. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994, 84:4164-4173.
38. Stewart K, Walsh S, Screen J, Jefferiss CM, Chainey J, Jordan GR, Beresford JN. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 1999, 14:1345-1356. 10.1359/jbmr.1999.14.8.1345, 10457267.
39. Dennis JE, Carbillet JP, Caplan AI, Charbord P. The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 2002, 170:73-82. 10.1159/000046182, 11731697.
40. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, Brahim J, Young M, Robey PG, Wang CY, Shi S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004, 364:149-155. 10.1016/S0140-6736(04)16627-0, 15246727.
41. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res & Ther 2007, 9:204. 10.1186/ar2116, 21595612.
42. Segawa Y, Muneta T, Makino H, Nimura A, Mochizuki T, Ju YJ, Ezura Y, Umezawa A, Sekiya I. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles. J Orthop Res 2009, 27:435-441. 10.1002/jor.20786, 18973232.
43. Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001, 98:10716-10721. 10.1073/pnas.191362598, 58532, 11535826.
44. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
45. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003, 121:368-374. 10.1046/j.1365-2141.2003.04284.x, 12694261.
46. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells 2007, 25:2896-2902. 10.1634/stemcells.2007-0637, 17901396.
47. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994, 15:490-495. 10.1016/0167-5699(94)90195-3, 7945775.
48. Simmons DL, Satterthwaite AB, Tenen DG, Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 1992, 148:267-271.
49. Salomon D, Ayalon O, Patel-King R, Hynes RO, Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 1992, 102:7-17.
50. Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991, 253:401-406. 10.1126/science.1650499, 1650499.
51. Cheng MT, Yang HW, Chen TH, Lee OK. Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Prolif 2009, 42:448-460. 10.1111/j.1365-2184.2009.00611.x, 19489981.
52. Rui YF, Lui PP, Li G, Fu SC, Lee YW, Chan KM. Isolation and Characterization of Multipotent Rat Tendon-Derived Stem Cells. Tissue Eng Part A 2010, 16:1549-1558. 10.1089/ten.tea.2009.0529, 20001227.
53. Nagineni CN, Amiel D, Green MH, Berchuck M, Akeson WH. Characterization of the intrinsic properties of the anterior cruciate and medial collateral ligament cells: an in vitro cell culture study. J Orthop Res 1992, 10:465-475. 10.1002/jor.1100100402, 1613622.
54. Indelicato PA. Non-operative treatment of complete tears of the medial collateral ligament of the knee. J Bone Joint Surg Am 1983, 65:323-329.
55. Kannus P. Long-term results of conservatively treated medial collateral ligament injuries of the knee joint. Clin Orthop Relat Res 1988, 226:103-112.
56. Reider B, Sathy MR, Talkington J, Blyznak N, Kollias S. Treatment of isolated medial collateral ligament injuries in athletes with early functional rehabilitation. A five-year follow-up study. Am J Sports Med 1994, 22:470-477. 10.1177/036354659402200406, 7943511.
57. Frank C, Amiel D, Woo SL, Akeson W. Normal ligament properties and ligament healing. Clin Orthop Relat Res 1985, 196:15-25.
58. Liang R, Woo SL, Takakura Y, Moon DK, Jia F, Abramowitch SD. Long-term effects of porcine small intestine submucosa on the healing of medial collateral ligament: a functional tissue engineering study. J Orthop Res 2006, 24:811-819. 10.1002/jor.20080, 16514641.
59. Musahl V, Abramowitch SD, Gilbert TW, Tsuda E, Wang JH, Badylak SF, Woo SL. The use of porcine small intestinal submucosa to enhance the healing of the medial collateral ligament--a functional tissue engineering study in rabbits. J Orthop Res 2004, 22:214-220. 10.1016/S0736-0266(03)00163-3, 14656683.